Donga Socio Holdings (000640) - Total Liabilities
Based on the latest financial reports, Donga Socio Holdings (000640) has total liabilities worth ₩974.23 Billion KRW (≈ $660.22 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Donga Socio Holdings - Total Liabilities Trend (2000–2024)
This chart illustrates how Donga Socio Holdings's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Donga Socio Holdings's working capital to evaluate short-term liquidity relative to the company's equity base.
Donga Socio Holdings Competitors by Total Liabilities
The table below lists competitors of Donga Socio Holdings ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Checkpoint Therapeutics Inc
NASDAQ:CKPT
|
USA | $17.87 Million |
|
HeidelbergCement India Limited
NSE:HEIDELBERG
|
India | Rs11.28 Billion |
|
Spear REIT Ltd
JSE:SEA
|
South Africa | ZAC2.19 Billion |
|
MeguREIT Israel
TA:MGRT
|
Israel | ILA4.72 Billion |
|
Emira Property Fund
JSE:EMI
|
South Africa | ZAC6.60 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩83.41 Billion |
|
Chongqing YuXin Pingrui Electronic Co. Ltd.
SHE:301107
|
China | CN¥330.26 Million |
|
Hiyes International Co Ltd
TW:2348
|
Taiwan | NT$37.42 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Donga Socio Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Donga Socio Holdings market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Donga Socio Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Donga Socio Holdings (2000–2024)
The table below shows the annual total liabilities of Donga Socio Holdings from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩966.55 Billion ≈ $655.01 Million |
+3.95% |
| 2023-12-31 | ₩929.80 Billion ≈ $630.11 Million |
+26.88% |
| 2022-12-31 | ₩732.79 Billion ≈ $496.60 Million |
+3.74% |
| 2021-12-31 | ₩706.35 Billion ≈ $478.68 Million |
+13.49% |
| 2020-12-31 | ₩622.38 Billion ≈ $421.78 Million |
+1.75% |
| 2019-12-31 | ₩611.67 Billion ≈ $414.52 Million |
+20.84% |
| 2018-12-31 | ₩506.17 Billion ≈ $343.02 Million |
-7.16% |
| 2017-12-31 | ₩545.20 Billion ≈ $369.47 Million |
+3.58% |
| 2016-12-31 | ₩526.36 Billion ≈ $356.71 Million |
-15.22% |
| 2015-12-31 | ₩620.88 Billion ≈ $420.76 Million |
+13.59% |
| 2014-12-31 | ₩546.59 Billion ≈ $370.42 Million |
+15.39% |
| 2013-12-31 | ₩473.68 Billion ≈ $321.00 Million |
-43.74% |
| 2012-12-31 | ₩841.87 Billion ≈ $570.52 Million |
+33.45% |
| 2011-12-31 | ₩630.85 Billion ≈ $427.52 Million |
+29.10% |
| 2010-12-31 | ₩488.66 Billion ≈ $331.16 Million |
+2.46% |
| 2009-12-31 | ₩476.92 Billion ≈ $323.20 Million |
+13.82% |
| 2008-12-31 | ₩419.00 Billion ≈ $283.95 Million |
+8.82% |
| 2007-12-31 | ₩385.03 Billion ≈ $260.93 Million |
-6.59% |
| 2006-12-31 | ₩412.19 Billion ≈ $279.34 Million |
+8.45% |
| 2005-12-31 | ₩380.07 Billion ≈ $257.57 Million |
-4.78% |
| 2004-12-31 | ₩399.17 Billion ≈ $270.51 Million |
-6.01% |
| 2003-12-31 | ₩424.69 Billion ≈ $287.81 Million |
+14.41% |
| 2002-12-31 | ₩371.20 Billion ≈ $251.55 Million |
-7.84% |
| 2001-12-31 | ₩402.76 Billion ≈ $272.95 Million |
+18.70% |
| 2000-12-31 | ₩339.30 Billion ≈ $229.94 Million |
-- |
About Donga Socio Holdings
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of S… Read more